Genmab — December 2017

[E_L]

it is not just cost; you can many more patients on the same day with the same number of chars and nurses

[Graneman]

@Helge, I know. Det har bla. været båret af en meget aggressiv og særdeles skiftende linje fra Lars Topholm og Carnegie, der har medvirket til at så tvivl om aktien. Men al den tvivl de har ført til markedet, har hidtil vist sig aldeles ubegrundet. Det er på kanten af det uetiske.

[E_L]

chairs

[E_L]

that is the sence i got Bulder, as far as i could hear the bad sound

[Graneman]

Nå - nok om Pandora og Vestas. Det her er jo en Genmab-chat. :9

[Bulder]

Will you ask him at Q&A?

[E_L]

maybe something for the Q&A

[E_L]

haha snap

[Bulder]

snap snap

[E_L]

i was actually just searching for that link from IMF video Durie and 2 others; may be worth posting again if you have it for those that havent seen yet

[E_L]

also on car-t

[E_L]

where PR mentioned how those trials had waiting lists for 1 year, and patients where carefully selected and vetted

[Bulder]

It's been posted 3 times already

[E_L]

this offcourse to get best results in such a small study

[E_L]

and i still couldnt find it back. forget it lol

[Graneman]

Juno er nu nede med 25% siden mandag. 7% bare i dag.
Just sayin'.

[Helge_LarsenPI-redaktør]

Very young patients in the study.

[Bulder]

but here it is https://www.youtube.com/watch?v=oqA2H5Q-YmQ&t=24s

[E_L]

yeah, ok, i would have still prefered to have had Juno this year mate...still more then doubled...

[E_L]

thanks